We are live on !
Find out more
RFCA
R&F Capital Advisors Portfolio holdings
AUM
$387M
Turnover
74.43%
This Fund
S&P 500
This Quarter Est. Return
+5.78%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$387M
AUM Growth
+$104M
(+37%)
Cap. Flow
+$95.8M
Cap. Flow % of AUM
Cap. Flow %
24.75%
Top 10 Holdings %
Top 10 Hldgs %
9.31%
Holding
915
New
429
Increased
127
Reduced
106
Closed
252
Avg Time Held
0.1
years
Top 10 Avg Time Held
0
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$3.65M |
| 2 |
Altria Group
MO
|
+$3.34M |
| 3 |
Abbott
ABT
|
+$3.17M |
| 4 |
ConocoPhillips
COP
|
+$2.84M |
| 5 |
Cboe Global Markets
CBOE
|
+$2.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$4.41M |
| 2 |
Cisco
CSCO
|
+$3.75M |
| 3 |
PG&E
PCG
|
+$2.96M |
| 4 |
Best Buy
BBY
|
+$2.9M |
| 5 |
Marsh
MRSH
|
+$2.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.94% |
| 2 | Consumer Discretionary | 12.95% |
| 3 | Healthcare | 12.73% |
| 4 | Industrials | 11.71% |
| 5 | Technology | 11.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
626
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $84K | 0.02% |
+2,099
| New | +$86.2K |
2017 Q1
0 quarters
|
|
627
Standard BioTools
LAB
$247M
| $83K | 0.02% |
+14,500
| New | +$91.9K |
2017 Q1
0 quarters
|
|
|
FCH
628
DELISTED
Felcor Lodging Trust
FCH
| $81K | 0.02% |
+10,771
| New | +$81.7K |
2017 Q1
0 quarters
|
|
629
Rocket Pharmaceuticals
RCKT
$239M
| $78K | 0.02% |
+9,778
| New | +$65.8K |
2017 Q1
0 quarters
|
|
630
DELISTED
Dynavax Technologies
DVAX
| $77K | 0.02% |
12,924
-31,462
| -71% | -$151K |
2016 Q4
1 quarter
|
|
631
DELISTED
Jive Software, Inc.
JIVE
| $77K | 0.02% |
+17,802
| New | +$75.4K |
2017 Q1
0 quarters
|
|
632
AudioCodes
AUDC
$271M
| $76K | 0.02% |
+10,888
| New | +$72.6K |
2017 Q1
0 quarters
|
|
633
Vince Holding Corp
VNCE
$166M
| $72K | 0.02% |
+4,629
| New | +$111K |
2017 Q1
0 quarters
|
|
634
DELISTED
Atlantic Power Corporation
AT
| $72K | 0.02% |
+27,052
| New | +$66.4K |
2017 Q1
0 quarters
|
|
|
CGI
635
DELISTED
Celadon Group Inc
CGI
| $72K | 0.02% |
+10,985
| New | +$89.8K |
2017 Q1
0 quarters
|
|
636
Crocs
CROX
$5.9B
| $71K | 0.02% |
10,097
-1,753
| -15% | -$12.2K |
2016 Q4
1 quarter
|
|
637
DELISTED
Immunogen Inc
IMGN
| $68K | 0.02% |
+17,649
| New | +$51.5K |
2017 Q1
0 quarters
|
|
638
Ballard Power Systems
BLDP
$551M
| $64K | 0.02% |
+29,047
| New | +$58.3K |
2017 Q1
0 quarters
|
|
|
RFP
639
DELISTED
Resolute Forest Products Inc.
RFP
| $63K | 0.02% |
+11,469
| New | +$56.9K |
2017 Q1
0 quarters
|
|
|
ONDK
640
DELISTED
On Deck Capital, Inc.
ONDK
| $62K | 0.02% |
+12,353
| New | +$61.8K |
2017 Q1
0 quarters
|
|
|
ACHN
641
DELISTED
Achillion Pharmaceuticals
ACHN
| $62K | 0.02% |
+14,620
| New | +$60.7K |
2017 Q1
0 quarters
|
|
642
DELISTED
Avinger, Inc. Common Stock
AVGR
| – | – |
0
| – | – |
2017 Q1
0 quarters
|
|
|
PETX
643
DELISTED
Aratana Therapeutics, Inc.
PETX
| $56K | 0.01% |
+10,506
| New | +$70.9K |
2017 Q1
0 quarters
|
|
|
CSLT
644
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $54K | 0.01% |
+14,702
| New | +$51.6K |
2017 Q1
0 quarters
|
|
645
Celldex Therapeutics
CLDX
$2.16B
| $53K | 0.01% |
+973
| New | +$50.7K |
2017 Q1
0 quarters
|
|
646
TETRA Technologies
TTI
$788M
| $51K | 0.01% |
+12,420
| New | +$55.9K |
2017 Q1
0 quarters
|
|
|
SRNE
647
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $51K | 0.01% |
+12,878
| New | +$64.6K |
2017 Q1
0 quarters
|
|
648
CEMIG Preferred Shares
CIG
$6.64B
| $49K | 0.01% |
+28,976
| New | +$45.1K |
2017 Q1
0 quarters
|
|
|
ACGN
649
DELISTED
Aceragen Inc
ACGN
| $49K | 0.01% |
145
-26
| -15% | -$6.27K |
2016 Q4
1 quarter
|
|
650
DELISTED
Stein Mart Inc
SMRT
| $47K | 0.01% |
+15,778
| New | +$55.9K |
2017 Q1
0 quarters
|
|
Similar funds
MGII
AL
KI
NAM
TM
PAM
IWMPD
IMIM
R&F Capital Advisors's Q1 2017 Portfolio in Review
As of Q1 2017, R&F Capital Advisors held 915 positions worth $387M, up 37% from $284M the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
R&F Capital Advisors deployed $95.8M of net new capital in Q1 2017, opening 429 new positions and adding to 127 existing holdings. Its largest new stake was Altria Group: 46,162 shares worth $3.3M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Baxter International, an estimated $4.41M trimmed.
- R&F Capital Advisors's largest Q1 2017 buy was Altria Group: 46,162 shares worth $3.3M.
- R&F Capital Advisors added most to Goldman Sachs in Q1 2017, an estimated $3.65M increase.
- R&F Capital Advisors's biggest Q1 2017 reduction was Baxter International, cutting an estimated $4.41M.
- R&F Capital Advisors fully exited Cisco in Q1 2017, selling an estimated $3.75M.
- R&F Capital Advisors's ten largest holdings make up 9.3% of its $387M portfolio in Q1 2017.
- R&F Capital Advisors opened 429 new positions and closed 252 in Q1 2017.
- R&F Capital Advisors's portfolio value rose 37% quarter-over-quarter to $387M.
Based on R&F Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.